| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |